REAL-WORLD COMPARISON OF HEALTH CARE UTILIZATION BETWEEN DULOXETINE INITIATORS AND PREGABALIN INITIATORS AMONG FIBROMYALGIA PATIENTS

被引：0
|
作者：
Peng, X. [1 ]
Sun, P. [2 ]
Wu, A. [3 ]
Andrews, J. S. [1 ]
Novick, D. [4 ]
Faries, D. [1 ]
Sun, S. [5 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Kailo Res Grp, Fishers, IN USA
[3] Kailo Res Grp, Los Angeles, CA USA
[4] Eli Lilly & Co, Windlesham, Surrey, England
[5] Kailo Res Grp, Fremont, CA USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1432
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A453 / A454
页数：2
相关论文
共 50 条
  • [31] Real-World Clinical Outcomes and Health Care Utilization in Patients With Severe Tricuspid Regurgitation
    Madhavan, Mahesh
    Barker, Colin
    Kemp, Lisa
    Mollenkopf, Sarah
    Ryan, Michael
    Gunnarsson, Candace
    Cohen, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (17) : B207 - B207
  • [32] HEALTH CARE RESOURCE UTILIZATION AND COSTS IN A SAMPLE OF REAL-WORLD PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA
    Grabner, M.
    Higuchi, K.
    Ramey, N.
    Toth, P.
    VALUE IN HEALTH, 2014, 17 (03) : A110 - A110
  • [33] Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide
    Knudsen, Jakob Schollhammer
    Thomsen, Reimar Wernich
    Pottegard, Anton
    Knop, Filip Krag
    Sorensen, Henrik Toft
    DIABETES CARE, 2018, 41 (09) : E133 - E135
  • [34] High-Throughput Screening for Prescribing Cascades Among Real-World Angiotensin-Converting Enzyme Inhibitor Initiators
    Ndai, Asinamai M.
    Smith, Kayla
    Keshwani, Shailina
    Choi, Jaeyoung
    Luvera, Michael
    Hunter, Julia
    Galvan, Rebecca
    Beachy, Tanner
    Molk, Matt
    Wright, Shannon
    Calvet, Marianna
    Pepine, Carl J.
    Schmidt, Stephan
    Vouri, Scott M.
    Morris, Earl J.
    Smith, Steven M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2025, 34 (03)
  • [35] Are statin trials in diabetes representative of real-world diabetes care: a population-based study on statin initiators in Finland
    Ruokoniemi, Paivi
    Sund, Reijo
    Arffman, Martti
    Helin-Salmivaara, Arja
    Huupponen, Risto
    Keskimaki, Ilmo
    Vehko, Tuulikki
    Korhonen, Maarit Jaana
    BMJ OPEN, 2014, 4 (06):
  • [36] Dosing Pattern Comparison Between Duloxetine and Pregabalin among Patients with Diabetic Peripheral Neuropathic Pain
    Sun, Peter
    Zhao, Yang
    Zhao, Zhenxiang
    Bernauer, Mark
    Watson, Peter
    PAIN PRACTICE, 2012, 12 (08) : 641 - 648
  • [37] Real-World Treatment Patterns, Health Care Utilization, and Costs Among Relapsed/Refractory Multiple Myeloma (rrMM) Patients
    Shao, Changxia
    Monberg, Matthew
    Cao, Xiting
    Zhou, Wei
    Zhong, Yichen
    Marinello, Patricia
    BLOOD, 2016, 128 (22)
  • [38] Real-world treatment and health care utilization among patients with Duchenne muscular dystrophy by race and ethnicity in a Medicaid population
    Posner, Nathaniel
    Manjelievskaia, Janna
    Talaga, Anna K.
    Richards, Megan
    Lew, Carolyn R.
    Merla, Valeria
    Alvir, Jose Maria Jimenez
    Nelson, Stanley F.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2025, 31 (02): : 205 - 213
  • [39] Real-World Dosing and Utilization of Ustekinumab Among Patients With Psoriasis
    Cai, Qian
    Carter, Chureen
    AbuDagga, Azza
    Schenkel, Brad
    Jones, Megan
    Tan, Hiangkiat
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2014, 6 (03) : 129 - +
  • [40] Real-World Genetic Testing Utilization Among Patients With Cardiomyopathy
    Morales, Ana
    Moretz, Chad
    Ren, Sheng
    Smith, Elizabeth
    Callis, Thomas E.
    Hall, Taryn
    Hatchell, Kathryn E.
    Nussbaum, Robert L.
    Regalado, Ellen
    Rojahn, Susan
    Vatta, Matteo
    Esplin, Edward D.
    Murillo, Jaime
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2024, 17 (01):
12345